More info
Novel potent SIRT7 inhibitor with an IC 50 of 325 nM, reducing deacetylase activity of SIRT7 in a dose-dependent manner, preventing tumor progression by increasing p53 stability through acetylation at K373/382, promoting apoptosis through caspase pathway